Find verified Lenvatinib Besylate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Lenvatinib Besylate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Lenvatinib Besylate API.
Alternate Names: CV6VKC887R
CAS No: 2414382-25-3
PubChem CID: 176489806
Mol Formula: C27H25ClN4O7S
Mol Weight: 585.0 g/mol
IUPAC Name: benzenesulfonic acid;4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide
API Description: Lenvatinib besylate is a targeted cancer therapy, specifically a tyrosine kinase inhibitor, used to treat advanced, metastatic, or progressive cancers, including differentiated thyroid cancer, hepatocellular carcinoma (liver cancer), and renal cell carcinoma (kidney cancer) in combination with pembrolizumab. It also treats advanced endometrial carcinoma.
